MEDDYGFA HAFAN
DOC FICTORIA, CAERNARFONCKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 138 | 170 | 81.2% | |
CKD 4 | 2008 | 129 | 160 | 80.6% | |
CKD 5 | 2009 | 29 | 33 | 87.9% | |
CKD 5 | 2010 | 22 | 27 | 81.5% | |
CKD 5 | 2011 | 32 | 36 | 88.9% | |
CKD 5 | 2012 | 32 | 36 | 88.9% | |
CKD 5 | 2013 | 29 | 35 | 82.9% | |
CKD003W | 2014 | 24 | 25 | 96.0% |